Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
- PMID: 30991959
- PMCID: PMC6469055
- DOI: 10.1186/s12876-019-0972-6
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
Abstract
Background: The prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among elderly have not been well described. Our aim was to assess the prevalence, risk factors and mortality of NAFLD in individuals older than 60 years.
Methods: The data from the Third National Health and Nutrition Examination Survey with linked mortality files were utilized. NAFLD was defined by United States Fatty Liver Index in the absence of other causes of liver disease. Cox proportional hazards models were used to assess all-cause and cardiovascular (CV) mortality. All analyses were performed using SAS software.
Results: Three thousand two hundred seventy-one NHANES-III participants were included. The prevalence rates from NAFLD were 40.3% (95% CI: 37.2-43.5%) and 39.2% (95% CI: 34.4-44.0%) among 60-74 and > 74 years old. Among aged 60-74, the risks for 5-year and 10-year all-cause mortality were associated with presence of NAFLD [adjusted hazard ratios: 1.60 (95% CI: 1.24-1.96) for 5-year and 1.22 (95%CI: 1.01-1.49) for 10-year]. CV mortality were higher in this group were (aHR: 2.12 (95% CI: 1.20-3.75) for 5-year and 1.06 (95%CI: 0.73-1.52) for 10-year]. In contrast, in individuals > 74 years old, diagnosis of NAFLD was not associated with all-cause or CVD mortality.
Conclusions: NAFLD is common among elderly population. Although NAFLD is associated with increased risk of mortality for 60-74-year-old individuals, this risk was not increased in those older than 74 years.
Keywords: Aging; Epidemiology; Metabolic syndrome; Mortality; Steatosis.
Conflict of interest statement
Ethics approval and consent to participate
This study has been approved by Internal Review Board of Inova Fairfax Hospital (Federal Assurance FWA00000573); the approval number is NHANES IRB: 12.1074.
Consent for publication
Not applicable.
Competing interests
Dr. Younossi is a consultant to BMS, Gilead, AbbVie, Intercept, and GSK. All other authors have no conflict of interest to disclose. The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2020 Jan;51(2):291-304. doi: 10.1111/apt.15580. Epub 2019 Nov 29. Aliment Pharmacol Ther. 2020. PMID: 31782543
-
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214. Medicine (Baltimore). 2018. PMID: 29595666 Free PMC article.
-
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22. Hepatology. 2016. PMID: 26707365 Review.
-
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820. World J Gastroenterol. 2015. PMID: 26078558 Free PMC article. Review.
-
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19. Metabolism. 2013. PMID: 22999011
Cited by
-
Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017-2020.J Health Popul Nutr. 2024 Mar 28;43(1):43. doi: 10.1186/s41043-024-00543-1. J Health Popul Nutr. 2024. PMID: 38549151 Free PMC article.
-
Associations of Skeletal Muscle Mass, Muscle Fat Infiltration, Mitochondrial Energetics, and Cardiorespiratory Fitness With Liver Fat Among Older Adults.J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4):glae047. doi: 10.1093/gerona/glae047. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38366047
-
The importance of age for liver-related mortality in patients with metabolic-dysfunction associated steatotic liver disease.Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):124-127. doi: 10.21037/hbsn-23-557. Epub 2024 Jan 9. Hepatobiliary Surg Nutr. 2024. PMID: 38322219 Free PMC article. No abstract available.
-
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population.Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):949-952. doi: 10.21037/hbsn-23-542. Epub 2023 Nov 9. Hepatobiliary Surg Nutr. 2023. PMID: 38115939 Free PMC article. No abstract available.
-
Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101209. doi: 10.1016/j.jceh.2023.06.009. Epub 2023 Jun 29. J Clin Exp Hepatol. 2024. PMID: 38076354 Review.
References
-
- Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism. 2013;62:352–360. doi: 10.1016/j.metabol.2012.08.005. - DOI - PubMed